Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Azithromycin: a new 15-membered macrolide.

G Treadway1

  • 1Pfizer Pharmaceuticals Group, Pfizer, Inc., New York, New York, USA.

The Japanese Journal of Antibiotics
|April 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.

International journal of antimicrobial agents·2001
Same author

Impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1998
Same author

Paediatric safety of azithromycin: worldwide experience.

The Journal of antimicrobial chemotherapy·1996
Same author

Clinical safety of intravenous amrinone--a review.

The American journal of cardiology·1985
Same author

Hexachlorophane--yes or no.

British medical journal·1977

Azithromycin, an azalide antibiotic, offers a broader spectrum of activity and improved pharmacokinetics compared to other macrolides. Its high tissue concentrations enable shorter treatment durations for various infections.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Azithromycin is a unique azalide antibiotic, distinct from traditional macrolides.
  • Its altered chemical structure confers advantages over existing macrolides.

Purpose of the Study:

  • To review the pharmacological and clinical profile of azithromycin.
  • To highlight its efficacy in treating various infections.

Main Methods:

  • Literature review of azithromycin's properties and clinical applications.
  • Analysis of pharmacokinetic and pharmacodynamic data.
  • Examination of clinical trial outcomes.

Main Results:

  • Azithromycin exhibits a broader spectrum of activity and a favorable safety profile.

Related Experiment Videos

  • It achieves high, prolonged cellular and tissue concentrations.
  • Shorter treatment courses are possible compared to other antibiotics.

    • Conclusions:

    • Azithromycin is effective for respiratory tract infections in adults and children.
    • New indications, including trachoma, are being developed.
    • Ongoing research explores its role in treating Chlamydia pneumoniae-related atherosclerosis.